[Frontiers in Bioscience 3, d631-636, July 1, 1998]
Reprints
PubMed
CAVEAT LECTOR




Table of Conents
 Previous Section   Next Section

MECHANISMS REGULATING THE BINDING ACTIVITY OF CD44 TO HYALURONIC ACID

Dacai Liu, Tong Liu, Ruliang, Li, and Man-Sun Sy

Institute of Pathology, Cancer Research Center, Case Western Reserve University School of Medicine, Cleveland, OH 44120

Received 4/27/98 Accepted 5/12/98

5. REFERENCES

1. Diamond, M. S., and T.A. Springer: The dynamic regulation of integrin adhesiveness. Cur. Biol 4, 506-517 (1994).

2. Ginsberg, M. H., Du, X., and E. D. Plow: Inside-out integrin signaling. Cur. Opin. in Cell Biol 4, 766-711 (1992).

3. Ruoslahti, E.: Fibronectin and its receptors. Annu. Rev. Biochem 57, 375-413 (1988).

4. Fidler, I. J: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38, 2651-2660 (1978)

5. Nicolson, G. L.: Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7, 143-188 (1988)

6. Lacy, B. E., and C. B. Underhill, C. BThe hyaluronate receptor is associated with actin filaments. J Cell Biol 105, 1395-404 (1987).

7. Sy, M. S., Liu, D., Schiavone, R., Ma, J., Mori, H., and Y. Guo. In: Interactions between CD44 and hyaluronic acid: Their role in tumor growth and metastasis. Attempts to understand metastasis formation. Ed. U. Schiag and P. W. Birchmeir. Current Topics in Microbiology and Immunology. Springer-Verlag 213, 129-154. (1996)

8. Lesley, J., Hyman, R., and P.W. Kincade: CD44 and its interaction with extracellular matrix. Adv. Immunol 54, 271-335 (1993).

9. Sherman, L., Sleeman, J., Herrlich, P., and H. Ponta: Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr. Opin. Cell Biol 6, 726-33 (1994).

10. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., and B, Seed: CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303-13 (1990)

11. Liao, H. X., Levesque, M. C., Patton, K., Bergamo, B., Jones, D., Moody, M. A., Telen, M. J., and B. F. Haynes: Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol 151, 6490-9 (1993).

12. Dacai, L and M.S. Sy : A Cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med 183, 1987-1994 (1996).

13. McKnight, G. S: Cyclic AMP second messenger systems. Curr. Opin. Cell Biol 3, 213-7 (1991).

14. Liu, D., Dong, X.Z., Mori, H., and M. S. Sy: Physiologic requirements and the role of cytoplasmic domain of CD44 in the interactions between CD44 and hyalduronic acid. Cell. Immunol 174, 73-83 (1996).

15. Huang, R. D., Smith, M. F., and W.L. Zahler: Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents. J. Cyclic Nucleotide Res 8, 385-94 (1982).

16. Friedrich, B., Cantrell, D. A., and M, Gullberg, M: Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens. Eur. J. Immunol 19, 17-23 (1989).

17. Parsey, M. V., and G. K. Lewis: Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells. J. Immunol 151, 1881-1893 (1993).

18. Rao, K. M: Phorbol esters and retinoids induce actin polymerization in human leukocytes. Cancer Lett 28, 253-262 (1985).

19. Geppert, T. D., and P. E. Lipsky: Association of various T cell surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol 146, 3296-3304 (1991).

20. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R., and P.W. Kincade: Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med 175, 257-266 (1992).

21. Lokeshwar, V. B., Fregien, N., and L. Y. Bourguignon: Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol 126, 1099-1109 (1994).

22. Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., and S. Tsukita: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol 126, 391-401 (1994).

23. Liu, D., A, and M. S. Sy: PMA induces covalent dimerization of CD44 involving a cysteine in the transmembrane domain. J. Immunol 159, 2702-2711 (1997).

24. Pure, E., Camp, R. L., Peritt, D., Panettieri, R. J., Lazaar, A. L., and S. Nayak. :Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med 181,55-62 (1995).

25. Lesley, J., English, N., Perschl, A., Gregoroff, J., and R. Hyman: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med 182,431-437 (1995).

26. Katoh, S., Z. Zheng, K. Oritani, T. Shimozato, T, and P. W. Kincade: Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp.Med 182, 419-425 (1995)

27. Bartolazzi, A., Nocks, A., Aruffo, A., Spring, F., and I. Stamenkovic: Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol 132,1199-1208 (1996).

28. Diamond, M. S., Staunton, D. E., Marlin, S. D., and T. A. Springer: Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65, 961-71 (1991).

29. Reilly, P. L., Woska, J. J., Jeanfavre, D. D., McNally, E., Rothlein, R., and B. J. Bormann: The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J. Immunol 155, 529-32 (1995).

30. Guo, Y. J., Ma, J., Wong, J. H., Lin, S. C., Chang, H. C., Bigby, M., and M. S. Sy: Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell. Immunol 152, 186-99 (1993).

31. Underhill, C: CD44: the hyaluronan receptor. J. Cell Sci. 103, 293-298 (1992).

32. Underhill, C. B., and B. P. Toole: Binding of hyaluronate to the surface of cultured cells. J. Cell Biol 82, 475-480 (1979).

33. Underhill, C. B., and A. Dorfman: The role of hyaluronic acid in intercellular adhesion of cultured mouse cells. Exp. Cell Res 117, 155-160 (1978).

34. Underhill, C. B: Interaction of hyaluronate with the surface of simian virus 4- transformed 3T3 cells. Aggregation and binding studies. J. Cell Sci 56, 177-180 (1982).

35. Underhill, C.B., G. Chi-Rosso, and B P. Toole: Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40 transformed 3T3 cells. J. Biol. Chem 258, 8086-8090 (1983).

36. Metzger, H: Transmembrane signaling: the joy of aggregation. J. Immunol 149, 1477-1487 (1992).

37. Rutledge, T., Cosson, P., Manolios, N., Bonifacino, J. S., and R. D. Klausner: Transmembrane helical interactions: zeta chain dimerization and functional association with the T cell antigen receptor. EMBO J 11, 3245-3254 (1992).

38 Perschl, A., J. Lesley, N. English, I. Trowbridge, and R. Hyman: Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol 25, 495-501 (1995).

39. Bourguignon, L. Y., E. L. Kalomiris, and V. B. Lokeshwar: Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J. Biol. Chem 266, 11761-11768 (1991).

40. Guo, Y. J., S. Lin, J. Wang, M. Bigby, and M. S. Sy.: Palmitoylation of CD44 interferes with CD3-mediated signaling in human T lymphocytes. Inter. Immunol 6, 213-220 (1994).

41. Olson, E. N., and G. Spizz: Fatty acylation of cellular proteins. J. Biol. Chem 261, 2458-2462 (1986).

42. Sefton, B. M., and J. E. Buss: The covalent modification of eucaryotic proteins with lipid. J. Cell Biol 104, 1449-1453 (1987).

43. Thomas, L., Byers, H. R., Vink, J., and I. Stamenkovic: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol 118, 971-977 (1992).

44. Cosson, P., Lankford, S. P., Bonifacino, J. S., and R. D, Klausner: Membrane protein association by potential intramembrane charge pairs [see comments]. Nature 351, 414-416.

45. Kalomiris E. L., and L. Y. W. Bourguignon: Lymphoma protein kinase C is associated with the transmembrane cylcoprotein, GP85, and may function in GP85-ankyrin binding. J. Biol. Chem 264, 8113-8119 (1989).

46. Carter, W. G., and E. A. Wayner: Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem 263, 4193-201 (1988).

47. Jalkanen, S., and Jalkanen, M: Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol 116, 817-825 (1992).

48. Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y., Kitamura, F., Yagita, H., Suzuki, K., and M. Miyasaka: A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J. Biol. Chem 270, 7437-7444 (1995).

49. Weber, G. F., Ashkar, S., Glimcher, M. J., and H. Cantor: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271, 509-512 (1996).

50. Miyamoto, S., Akiyama, S. K., and K. M. Yamada: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267, 883-885 (1995).